āagman

Not investment advice. Data and computed figures, for information only.

Jubilant Pharmova Ltd

NSE: JUBLPHARMA
₹938.20
−₹0.70 (−0.07%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹14,845 Cr
CMP
₹938.20
52-wk High / Low
₹1,185 / 786
P/E
38.2
P/B
2.1
Book Value
₹445.0
Div Yield
0.54%
ROCE
9.0%
ROE
6.5%
Face Value
₹1
D/E
0.51

Price−16.5% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 15 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
4
/ 9
4 of 9 F-score tests passed
Graham Number
₹501
√(22.5 × EPS × book value per share)
ROIC
5.0%
vs 11.2% sector median
Cash flow to profit
3.08
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−413
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
5.2%
ROE × earnings retention ratio
ROE stability
5.1
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII −0.03DII +0.77
Latest quarter vs the previous one
Cash-accrual divergence
−6.0%
of assets
Low = accruals track cash flow
Strengths
+PE of 38.2x is below the sector median of 45.9x
Watch-outs
−Latest ROCE of 9% trails the sector median of 17%
−Price trades below its 200-day moving average (1.0x)
−Promoter holding fell by 3pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,5871,6801,6771,7591,7321,7521,8221,9291,9011,9662,1222,2902,229
Expenses1,4191,4381,4591,4871,4801,4631,5351,5841,6111,6251,8331,9511,981
Operating Profit168242218271252289287345290341289339248
OPM %10.6%14.4%13.0%15.4%14.5%16.5%15.8%17.9%15.3%17.3%13.6%14.8%11.1%
Other Income91949−1514108−109124−191020
Interest62667173716156534950565654
Depreciation9097951019191919598105121117127
Profit before tax2598101−545001441302061541909317686
Net Profit66266−624821021011511021205611956
EPS (₹)0.403.924.19−3.6830.266.456.339.646.467.553.517.503.55

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5,7515,7495,8617,5189,1115,9766,0996,1306,2826,7037,2348,2808,608
Expenses5,1414,4934,5105,9957,3674,4284,6954,9805,5035,8026,0617,0207,390
Operating Profit6101,2561,3521,5221,7441,5481,4031,1507799011,1731,2601,218
OPM %10.6%21.8%23.1%20.2%19.1%25.9%23.0%18.8%12.4%13.4%16.2%15.2%14.1%
Other Income8641936−2492252638−9−76416715
Interest368371341284220200184145188272240212217
Depreciation288347291415371340349382554382369440470
Profit before tax405427388599041,2331,13363028170981614546
Net Profit−40387575634577898836413−6573836398351
EPS (₹)−3.6324.6036.1440.3536.0656.3952.4725.98−3.834.8452.6925.0222.11

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital161616161616161616161616—
Reserves2,4382,9513,4204,0714,7935,5884,7265,3035,3835,4186,2397,077—
Borrowings4,7934,4934,0453,4694,8404,8082,8303,1923,6773,6642,7313,615—
Other Liabilities1,3721,2801,4171,9021,6701,8981,1921,3191,8532,2403,5984,564—
Total Liabilities8,6198,7408,8999,45711,31912,3108,7639,83010,92911,33812,58415,272—
Fixed Assets4,9115,1045,1075,4015,6486,3404,6094,8715,1835,0915,1766,966—
CWIP5976116846719017688971,0901,5622,1033,6304,040—
Investments408510312411569241239256424461—
Other Assets3,0712,9393,0063,2624,6545,1333,0173,6313,9284,1013,7354,205—
Total Assets8,6198,7408,8999,45711,31912,3108,7639,83010,92911,33812,58415,272—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity7727831,0991,2681,3031,1221,5431,7848386619711,0721,227
Cash from Investing Activity−164−362−309−465−614−1,018−267−727−323−474−596512−1,143
Cash from Financing Activity−414−503−843−686−901657−1,050−1,709−33−157−432−1,45395
Net Cash Flow194−82−52117−212761225−65248230−58132179

Ratios

As of 31 Mar 2026
13 periods
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %11.06.013.015.015.016.015.012.010.03.07.010.09.0
ROE %————————————6.5
EPS (₹)6.84−3.6324.6036.1440.3536.0656.3952.4725.98−3.834.8452.6925.02
Book Value (₹)————————————445.0
Face Value (₹)————————————1
P/E————————————38.2
Div Yield %————————————0.54
NPM %2.4−0.76.79.88.46.514.513.16.7−1.01.110.94.8
OPM %17.011.022.023.020.019.026.023.019.012.013.016.015.0
D/E1.671.951.511.180.851.010.860.600.600.680.670.440.51
P/B————————————2.1

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+4.0%
5 years+6.0%
3 years+10.0%
TTM+16.0%
Compounded profit growth
10 years+1.0%
5 years−13.0%
3 years+47.0%
TTM−20.0%
Stock price CAGR
10 years+5.0%
5 years+8.0%
3 years+31.0%
Last year−17.0%
Return on equity
10 years9.0%
5 years3.0%
3 years5.0%
Last year7.0%

Shareholding pattern

As of 31 Mar 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters54.02%54.02%50.68%50.68%50.68%50.68%50.68%50.67%50.67%50.67%47.67%47.67%
FIIs20.70%20.70%23.04%26.74%27.91%25.69%23.45%23.22%19.06%17.23%15.90%15.87%
DIIs3.72%3.72%6.00%4.78%1.87%1.28%0.63%1.62%3.77%7.05%11.63%12.40%
Government0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.24%0.00%0.00%0.00%0.00%
Public19.32%19.32%18.08%17.80%19.54%22.29%25.18%23.11%25.91%24.48%24.25%23.50%
No. of shareholders36,54636,54638,50643,18248,25761,9421,08,06397,93592,26496,52686,34782,703
Change since Jun 2023 (pp)
Promoters −6.35FIIs −4.83DIIs +8.68Public +4.18

Documents

As of 11 Oct 2026
Announcements
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015Board Meeting Intimation for To Consider And Approve Raising Of Funds Through The Issuance Of Non-Convertible Debentures (Ncds) And/Or Such Other Securities As May Be Permitted Under Applicable Laws, And To Approve Seeking Shareholders'' Approval, As May Be RequiredCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Closure of Trading WindowSpecimen Letter Sent To Shareholders For Withheld Of Dividend For FY 2025-26
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026PPTMay 2026TranscriptMay 2026PPTFeb 2026PPTOct 2025PPTJul 2025TranscriptJul 2025PPT

Corporate actions

As of 24 Jul 2026
24 Jul 2026DIVIDENDDividend - Rs 5 Per Share—
25 Jul 2025DIVIDENDDividend - Rs 5 Per Share—
2 Aug 2024DIVIDENDDividend - Rs 5 Per Share—
10 Aug 2023DIVIDENDDividend - Rs 5 Per Share—
11 Aug 2022DIVIDENDDividend - Rs 5 Per Share—
5 Aug 2021DIVIDEND Dividend - Rs 5 Per Share—
4 Feb 2021DEMERGER Demerger—
9 Mar 2020DIVIDEND Interim Dividend - Rs 5 Per Share—
12 Sep 2019DIVIDEND Annual General Meeting/Dividend - Rs 4.50 Per Share—
12 Sep 2018DIVIDEND Annual General Meeting/Dividend Rs 3 Per Share—
16 Aug 2017DIVIDEND Annual General Meeting/ Dividend - Rs 3/- Per Share—
18 Aug 2016DIVIDEND Annual General Meeting/ Dividend - Rs 3/- Per Share—
20 Aug 2015DIVIDEND Annual General Meeting/ Dividend - Rs 3/- Per Share—
21 Aug 2014DIVIDENDAnnual General Meeting / Dividend - Rs 3/- Per Share—
14 Aug 2013DIVIDENDAnnual General Meeting And Dividend Rs.3/- Per Share—
14 Aug 2012DIVIDENDAnnual General Meeting/ Dividend Rs 3 Per Share—
10 Aug 2011DIVIDENDAnnual General Meeting And Dividend Rs.2/- Per Share—
25 Nov 2010DEMERGERScheme Of Demerger—
17 Sep 2010DIVIDENDAnnual General Meeting And Dividend Rs.2/- Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman